Global Flow Diverters Market - 2023-2030

Global Flow Diverters Market - 2023-2030

Global Flow Diverters Market reached US$ XX billion in 2022 and is expected to reach US$ XX billion by 2030, growing with a CAGR of XX% during the forecast period 2023-2030.

Flow diversion is a technique in which your surgeon uses a catheter to place a stent (a soft, flexible mesh tube) into the blood vessel where an aneurysm has formed. This process immediately diverts the flow of blood away from the aneurysm itself. The increase in the launches and technological advancements of devices drive market growth.

The North America region is expected to hold a significant position in the market share. The increase in the number of launches by the key companies is expected to hold the region in the dominant position. Surpass flow diverter segment holds a significant market share. The advantage of the device over the other types is holding the segment in the dominant market share.

Dynamics

Rise in the Number of Launches of the Products will Accelerate the Market Growth

An increased number of product launches and an increase in technological advancements will drive market growth. For instance, on June 1, 2022, Medtronic, a wholly owned subsidiary of Medtronic plc, launched a CE-marked fourth-generation flow diverter, Pipeline Vantage with Shield Technology, for the endovascular treatment of brain aneurysms. Pipeline Vantage with Shield Technology is a new flow diverter with enhanced design features for both the delivery system and implant.

On October 20, 2021, Evasc Neurovascular developed the third generation of its eCLIPs device, the eCLIPs Bifurcation Flow Diverter. The new device is classified as a flow diverter, with a leaf density of 35%, which is 60% higher than the existing eCLIPs devices. Thus, an increase in the number of launches and advancements of the products will drive the market growth.

Increase in the Prevalence of Brain Aneurysm Cases will Elevate the Market Growth

An increase in the number of brain aneurysm cases is driving the growth of the market. For instance, according to the Brain Aneurysm Foundation, the annual rupture rate is approximately 8 – 10 per 100,000 people. About 30,000 people in the United States suffer a brain aneurysm rupture each year.

A brain aneurysm ruptures every 18 minutes. Almost 500,000 deaths worldwide each year are caused by brain aneurysms, and half the victims are younger than 50. Brain aneurysms are most prevalent in people ages 35 to 60 but can also occur in children. Most aneurysms develop after the age of 40. Ruptured brain aneurysms account for 3-5% of all new strokes. Thus, an increase in aneurysm cases will drive the growth of the market in the forecast period.

Complications Associated with Flow Diverters can Decline the Market Growth

The complications associated with using flow diverters can cause a decline in market growth. The majority of flow diverter complications occurred during the perioperative period. Thromboembolic complications in flow diversion include acute and hyperacute stent thrombosis, large-vessel occlusion, and perforator or side-branch occlusion.

Complications include hematoma (blood clot collection at the groin) and hemorrhagic or ischemic stroke, which can be minor or major. There are risks associated with flow diverters, including in-stent thrombosis, perianeurysmal edema, distant and delayed hemorrhages, and perforator occlusions.

Segment Analysis

The global flow diverters market is segmented based on type, material, application, end-user and region.

Surpass Flow Diverter Segment Holds a Significant Position in the Market Share

Surpass flow diverter segment holds a dominant market share due to the benefits and advantages of the devices over the rest. The surpass flow diverters are more advantageous because they provide a better aneurysm occlusion, lower complication rate, and improved long-term outcomes compared to the other devices.

Surpass flow diverters are mostly used in complex conditions to divert the blood flow away from the aneurysms. The Surpass Streamline flow diverter (SSFD) possesses four attributes that may offer an important advantage in the treatment of complex pathologies, including utilization of an over-the-wire (OTW) delivery system, greater device length, larger potential diameter, and propensity to open in tortuosity. Thus, the advantages of the device hold the dominant market share in the forecast period.

Geographical Penetration

North America region holds the largest market share in the global flow diverters market

The increase in the number of launches in the region holds the market’s dominant share. With the presence of major companies and the demand for treating aneurysm disease conditions, the launches have been increasing.

On March 1, 2023, PT Healthcare has conducted a workshop. And has launched the DERIVO 2 Embolisation Device. The DERIVO2 Embolisation Device is the next generation of the proven and reliable flow diverter optimized for different treatment options. Thus, the increase in the launches of the products will drive the growth of the region’s market share.

COVID-19 Impact Analysis

The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global flow diverters market. COVID-19 pandemic caused disruption in consultation for diseases such as cerebral aneurysms and hypertension. The delayed consultations have impacted the treatment processes and, thus, impacted the market growth.

The delay in manufacturing the flow diverters by the key companies and the lack of investments by the partner companies have significantly impacted the market growth. Thus, COVID-19 has impacted the market growth negatively. Thus, this factor was anticipated to restrain the demand for flow diverter devices and restrain the market growth.

By Type
• Pipeline Embolization Device
• Silk Flow Diverter
• Surpass Flow Diverter
• Flow Redirection Endoluminal Device

By Material
• Cobalt-Chromium
• Nitinol-Alloy
• Others

By Application
• Cerebral Aneurysms
• Multiple Intracranial Aneurysms
• Others

By End-User
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Spain
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The global flow diverters market is fragmented, with the presence of many local and international players including Medtronic, Balt Extrusion Sa, Phenhttps, Phenox Gmbh, Acandis Gmbh, MicroPort Scientific Corporation, MicroVention Inc., Cerus Endovascular Inc., Evasc Neurovascular Enterprises etc. are the leading companies with a significant market share.

Why Purchase the Report?
• To visualize the global flow diverters market segmentation based on type, material, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of flow diverters market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global flow diverters market report would provide approximately 61 tables, 58 figures, and 186 Pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies